139 related articles for article (PubMed ID: 9466328)
1. Development of hyperthyroidism during long term interferon therapy in a patient with chronic myelogenous leukemia: case report.
Ozet A; Ozet G; Calişkaner Z; Kömürcü S; Oztürk B
Endocr J; 1997 Oct; 44(5):715-7. PubMed ID: 9466328
[TBL] [Abstract][Full Text] [Related]
2. Interferon-alpha-induced focal segmental glomerulosclerosis in chronic myelogenous leukemia: a case report and review of the literature.
Bremer CT; Lastrapes A; Alper AB; Mudad R
Am J Clin Oncol; 2003 Jun; 26(3):262-4. PubMed ID: 12796597
[TBL] [Abstract][Full Text] [Related]
3. Thrombotic thrombocytopenic purpura complicating chronic myelogenous leukemia treated with interferon-alpha. A report of two successfully treated patients.
Rachmani R; Avigdor A; Youkla M; Raanani P; Zilber M; Ravid M; Ben-Bassat I
Acta Haematol; 1998; 100(4):204-6. PubMed ID: 9973644
[TBL] [Abstract][Full Text] [Related]
4. Result of interferon-alpha therapy in patients with chronic myelogenous leukemia 60 years of age and older.
Cortes J; Kantarjian H; O'Brien S; Robertson LE; Pierce S; Talpaz M
Am J Med; 1996 Apr; 100(4):452-5. PubMed ID: 8610733
[TBL] [Abstract][Full Text] [Related]
5. Parkinsonism associated with interferon alpha therapy for chronic myelogenous leukemia.
Sarasombath P; Sumida K; Kaku DA
Hawaii Med J; 2002 Mar; 61(3):48, 57. PubMed ID: 11965836
[TBL] [Abstract][Full Text] [Related]
6. [Interferon-alpha-associated polyarthritis. Possible induction of seropositive rheumatoid arthritis by interferon-alpha: two case reports and review of the literature].
Kötter I; Müller CA; Einsele H; Mohren M; Kanz L
Z Rheumatol; 1999 Aug; 58(4):185-95. PubMed ID: 10502017
[TBL] [Abstract][Full Text] [Related]
7. [Marked reduction of BCR-ABL fusion chromosome positive cells with interferon therapy combined with short-term imatinib in chronic myelogenous leukemia].
Ajima A; Takayama N; Hasegawa Y; Kojima H; Nagasawa T
Gan To Kagaku Ryoho; 2003 Nov; 30(12):1997-9. PubMed ID: 14650975
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune thrombocytopenia in chronic myeloid leukemia treated with interferon-alpha: differential diagnosis and possible pathogenesis.
Herishanu Y; Trestman S; Kirgner I; Rachmani R; Naparstek E
Leuk Lymphoma; 2003 Dec; 44(12):2103-8. PubMed ID: 14959855
[TBL] [Abstract][Full Text] [Related]
9. Use of hydroxyurea and alpha-interferon in chronic myeloid leukemia during pregnancy: a case report.
Baykal C; Zengin N; Coşkun F; Güler N; Ayhan A
Eur J Gynaecol Oncol; 2000; 21(1):89-90. PubMed ID: 10726630
[No Abstract] [Full Text] [Related]
10. Interferon-alpha-induced pure red cell aplasia following chronic myelogenous leukemia.
Tomita N; Motomura S; Ishigatsubo Y
Anticancer Drugs; 2001 Jan; 12(1):7-8. PubMed ID: 11272289
[TBL] [Abstract][Full Text] [Related]
11. Thrombotic microangiopathy associated with alpha-interferon therapy for chronic myeloid leukaemia.
Galesic K; Bozic B; Racic I; Scukanec-Spoljar M
Nephrology (Carlton); 2006 Feb; 11(1):49-52. PubMed ID: 16509932
[TBL] [Abstract][Full Text] [Related]
12. Hematological and cytogenetic response of interferon alpha 2b alone and combined interferon alpha plus cytarabine as a first-line treatment in chronic myeloid leukemia.
Tóthová E; Fricová M; Kafková A; Stecová N; Guman T; Raffac S; Hlebasková M
Neoplasma; 2000; 47(2):125-8. PubMed ID: 10985480
[TBL] [Abstract][Full Text] [Related]
13. The interferon-alpha revival in CML.
Talpaz M; Mercer J; Hehlmann R
Ann Hematol; 2015 Apr; 94 Suppl 2():S195-207. PubMed ID: 25814086
[TBL] [Abstract][Full Text] [Related]
14. [Chronic myelogenous leukemia with long-term hypoplasia induced by alpha-interferon and hydroxyurea].
Motomura S; Sakai R; Tomita N; Fujimaki K; Hattori M; Fujisawa S; Mohri H; Takahashi N; Maruta A; Kodama F; Okubo T
Rinsho Ketsueki; 1998 Apr; 39(4):302-7. PubMed ID: 9597898
[TBL] [Abstract][Full Text] [Related]
15. Renal thrombotic microangiopathy induced by interferon-alpha.
Badid C; McGregor B; Faivre JM; Guerard A; Juillard L; Fouque D; Laville M
Nephrol Dial Transplant; 2001 Apr; 16(4):846-8. PubMed ID: 11274286
[No Abstract] [Full Text] [Related]
16. [Autoimmune diseases and treatment with interferon-alpha: review of the literature apropos of a case of hyperthyroidism].
Dupont J; Orgiazzi J; Burger A
Rev Med Interne; 1993 Feb; 14(2):93-9. PubMed ID: 8378632
[TBL] [Abstract][Full Text] [Related]
17. Juvenile chronic myelogenous leukemia: therapeutic trial with interferon alpha 2B.
Agarwal BR; Gulvady A; Joshi K; Khemani S; Currimbhoy ZE
Indian Pediatr; 1995 Sep; 32(9):1002-4. PubMed ID: 8935266
[No Abstract] [Full Text] [Related]
18. Thrombotic microangiopathy associated with alpha-interferon therapy for chronic myelocytic leukemia.
Honda K; Ando A; Endo M; Shimizu K; Higashihara M; Nitta K; Nihei H
Am J Kidney Dis; 1997 Jul; 30(1):123-30. PubMed ID: 9214412
[TBL] [Abstract][Full Text] [Related]
19. Low-dose interferon-alpha 2b combined with hydroxyurea versus hydroxyurea alone for chronic myelogenous leukemia.
Benelux CML Study Group
Bone Marrow Transplant; 1996 May; 17 Suppl 3():S19-20. PubMed ID: 8769694
[No Abstract] [Full Text] [Related]
20. [Treatment of chronic myeloid leukemia with interferon-alpha].
Szomor A; Molnár L; Nagy A; Dávid M; Alizadeh H; Kecskés M; Vidra T; Kereskai L; Pajor L; Losonczy H
Orv Hetil; 2000 Nov; 141(48):2601-4. PubMed ID: 11141958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
